NAD+/MOTS-c/5-Amino-1MQ Peptide Blend Research
Versatile Use: Ideal for diluting or dissolving various medications, it is widely used in hospitals and clinics
Unregulated peptide use poses a significant risk due to inconsistent dosing, contaminants, and lack of clinical oversight. Harvey et al., Therapeutic Advances in Drug Safety Legal Status and Testing Concerns With 5-Amino-1MQ 5-Amino-1MQ exists in a regulatory gray area it's not illegal, but it's not FDA-approved for human use either
The published medical literature includes discussion of BPC-157 as having been explored for GI indications (including a compound referred to as PL 14736 in phase II context), but the human clinical evidence base for the musculoskeletal claims people make online is not robust
Accepted diagnoses include pernicious anemia (D51.0), documented malabsorption conditions, and confirmed B12 deficiency (E53.8)